about
Stromal effects on mammary gland development and breast cancerInsulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function.The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfacesAcute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland functionEpigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosisDownregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1.RelA-Induced Interferon Response Negatively Regulates ProliferationApoptosis regulation in the mammary gland.Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation.Mammary involution and breast cancer risk: transgenic models and clinical studies.The spectrum of STAT functions in mammary gland developmentIRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.p55PIK transcriptionally activated by MZF1 promotes colorectal cancer cell proliferation.Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.Mullerian inhibiting substance promotes interferon gamma-induced gene expression and apoptosis in breast cancer cells.Activating transcription factor 4 overexpression inhibits proliferation and differentiation of mammary epithelium resulting in impaired lactation and accelerated involution.Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP
P2860
Q24645558-91F58D29-11C7-4DDE-B316-EACAA5405604Q24800144-E68B4A0C-F25A-4DC5-A99B-E569A9F37AA3Q28263907-73FEB3D1-787D-42B3-B0B3-E14A44F93811Q28767351-57DB0892-C539-450E-B4AA-646C7936584EQ34087012-C44E7BC7-6B4E-42FB-AF78-E86A0DAEE96AQ34168187-DF6F6B4D-7F10-43F5-BB74-35F64EEABFFCQ35804406-1B44B923-5206-4C1B-8E18-B54E3B92C648Q35854115-C93C28E6-14D8-4894-AD3A-47EDA5193AA4Q36939732-613BAB8E-B9C3-4DCF-8C3A-B6484AF2611DQ37220983-3B209E5E-0BA3-4040-8472-3FB0A4479FCBQ38140889-58C53371-2E98-4BA3-88CB-522131A42393Q38870837-5ECAD573-2793-4D9E-9710-ECA60D3BF9AAQ39178601-73CBFC9F-187E-44AF-BCD3-0F8D161D0F2CQ39262264-20B6AB75-F166-47E6-8206-AA41194EEC11Q40628176-2E971D83-5DF7-4F55-9D09-4FC7ECFD4D81Q44336479-31AC05DD-D349-49F5-BBFB-29998222C130Q58767201-A2C2B11A-27D1-4806-A1FC-5F337B057148
P2860
description
im Dezember 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2000
@uk
name
A novel role for IRF-1 as a suppressor of apoptosis
@en
A novel role for IRF-1 as a suppressor of apoptosis
@nl
type
label
A novel role for IRF-1 as a suppressor of apoptosis
@en
A novel role for IRF-1 as a suppressor of apoptosis
@nl
prefLabel
A novel role for IRF-1 as a suppressor of apoptosis
@en
A novel role for IRF-1 as a suppressor of apoptosis
@nl
P2093
P2860
P356
P1433
P1476
A novel role for IRF-1 as a suppressor of apoptosis
@en
P2093
Alan R Clarke
Christine J Watson
David J Flint
Eleanor K Duff
Elizabeth Tonner
Paula C Lourenco
Rachel S Chapman
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204016
P407
P577
2000-12-01T00:00:00Z